Remission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy [2]

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'Remission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy [2]'. Together they form a unique fingerprint.